Ipamorelin, the first selective growth hormone secretagogue
Preclinical pharmacology characterized the pentapeptide ipamorelin and compared growth hormone release with other secretagogues in laboratory models.
Study limitations
Selectivity in these models does not establish long-term human safety or benefits for sleep, injury recovery, or athletic performance.
